Capital Research Global Investors Eli Lilly & CO Transaction History

Capital Research Global Investors

$440 Billion
Q1 2025

A detailed history of Capital Research Global Investors transactions in Eli Lilly & CO stock. As of the latest transaction made, Capital Research Global Investors holds 15,747,463 shares of LLY stock, worth $12.4 Billion. This represents 2.95% of its overall portfolio holdings.

Number of Shares

15,747,463

Previous 10,757,511 46.39%

Holding current value

$12.4 Billion

Previous $8.3 Billion 56.61%

% of portfolio

2.95%

Previous 1.78%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$725.72 - $929.72 $3.62 Billion - $4.64 Billion	4,989,952 Added 46.39%	15,747,463 $13 Billion
Q4 2024 Feb 13, 2025	BUY	$727.2 - $932.06 $1.09 Billion - $1.39 Billion	1,493,673 Added 16.12%	10,757,511 $8.3 Billion
Q3 2024 Nov 13, 2024	BUY	$772.14 - $960.02 $111 Million - $139 Million	144,304 Added 1.58%	9,263,838 $8.21 Billion
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $789 Million - $989 Million	1,088,003 Added 13.55%	9,119,534 $8.26 Billion
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $269 Million - $360 Million	453,939 Added 5.99%	8,031,531 $6.25 Billion
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $171 Million - $201 Million	325,342 Added 4.49%	7,577,592 $4.42 Billion
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $204 Million - $281 Million	469,273 Added 6.92%	7,252,250 $3.9 Billion
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $229 Million - $307 Million	654,026 Added 10.67%	6,782,977 $3.18 Billion
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $322 Million - $379 Million	1,037,933 Added 20.39%	6,128,951 $2.1 Billion
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $106 Million - $123 Million	328,249 Added 6.89%	5,091,018 $1.86 Billion
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $548 Million - $625 Million	1,848,662 Added 63.44%	4,762,769 $1.54 Billion
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $812 Million - $954 Million	2,914,107 New	2,914,107 $945 Million

Others Institutions Holding LLY

# of Institutions

4,393

Shares Held

823M

Call Options Held

10M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $748B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.

Account

Capital Research Global Investors Eli Lilly & CO Transaction History